LGI1 antibody (AA 206-218)
Quick Overview for LGI1 antibody (AA 206-218) (ABIN7043306)
Target
See all LGI1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 206-218
-
Purpose
- A Rabbit Polyclonal Antibody to LGI1
-
Specificity
- LRRCT domain
-
Cross-Reactivity
- Mouse, Rat
-
Predicted Reactivity
- Mouse - identical, human - 12,13 amino acid residues identical
-
Characteristics
- Anti-LGI1 Antibody (ABIN7043306, ABIN7044578 and ABIN7044579) is a highly selective antibody directed against an epitope of the rat protein. The antibody can be used in western blot analysis. It has been designed to recognize LGI1 from human, mouse, and rat samples.
-
Purification
- Affinity purified on immobilized antigen.
-
Immunogen
-
Immunogen: Synthetic peptide
Immunogen Sequence: (C)YKKRKINSLSPKD, corresponding to amino acid residues 206-218 of rat LGI1
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Antigen preadsorption control: 1 μg peptide per 1 μg antibody
Application Dilutions Immunohistochemistry paraffin embedded sections ihc: N/A
Application Dilutions Western blot wb: 1:200
-
Comment
-
Negative Control: (ABIN7235886)
Blocking Peptide: (ABIN7235886)
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.
-
Concentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.
Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).
-
-
- LGI1 (Leucine-Rich, Glioma Inactivated 1 (LGI1))
-
Alternative Name
- LGI1
-
Background
-
Leucine-rich glioma-inactivated protein 1, Epitempin-1, EPT,The leucine-rich glioma inactivated (LGI) gene subfamily contains four highly conserved members (LGI1, 2, 3 and 4), which have been described in human, mouse and other mammalians. LGI1 is mainly expressed in the dentate gyrus and the CA3 field of the hippocampus1.The predicted structure of the LGI1 protein comprises, starting from the N-terminal, a signal peptide, four leucine-rich repeats (LRR) flanked on both sides by conserved cysteine clusters, and seven copies of a repeat of about 45 residues, named EPTP or EAR, probably forming a β-propeller structural domain. Both LRR and β-propeller domains mediate protein-protein interactions, each motif defining a distinct family of proteins.LGI1 is associated with a post-synaptic complex containing PSD-95 and ADAM22, a receptor associated with the post-synaptic membrane. Through specific binding to ADAM22, LGI1 participates in the control of synaptic strength at excitatory synapses, whose malfunction may result in epilepsy.LGI1 has been linked to several different clinical phenotypes including: malignant progression of glioma and autosomal dominant lateral temporal epilepsy, a rare familial partial epilepsy syndrome. The LGI1 gene has been shown to be frequently downregulated in malignant gliomas and to regulate invasiveness of some glioma cell lines by driving the expression of matrix metalloproteinases through the ERK 1/2 pathway. These findings suggest that LGI1 may serve as a tumor metastasis suppressor gene2. In addition, antibodies to LGI1 complexed with the KV1.1 potassium channel have been found in brain extracts from patients with limbic encephalitis3.
Alternative names: LGI1, Leucine-rich glioma-inactivated protein 1, Epitempin-1, EPT -
Gene ID
- 252892
-
NCBI Accession
- NM_005097
-
UniProt
- Q8K4Y5
Target
-